Since over half of patients with gastric cancer and splenic metastases do not present relevant clinical symptoms, it is important to dynamically determine the values of the tumor markers CEA and CA 19-9, with their increase being confirmed in dynamics [6,7]. Here, CEACAM5 is linked to gastric cancer.